Case Report: Extending dosing intervals of biologics in adults severe asthma: a case series
For patients whose asthma control improves after initiating biological therapy, extending the dosing interval may be a feasible treatment option. Given the retrospective, single-center design and small sample size, these findings are exploratory and generate hypotheses that require validation in larger, prospective studies.
Authors
- Yoshihiro Funaki (ORCID: https://orcid.org/0000-0002-5641-1592)
- Genki Inui (ORCID: https://orcid.org/0000-0002-5604-7487)
- Hiroki Kohno (ORCID: https://orcid.org/0000-0003-2947-6216)
- Shin Kitatani
- Masato Morita (ORCID: https://orcid.org/0000-0002-2765-2338)
- Miyu Nishigami
- Hiroyuki Tanaka (ORCID: https://orcid.org/0000-0002-7681-8410)
- Akira Yamasaki (ORCID: https://orcid.org/0000-0001-8214-4822)
- Miki Takata
- Tomoya Harada
- Hiroki Ishikawa
- Ryota Okazaki
Institutions
- Keisen University (JP)
- Tottori Prefectural Kousei Hospital (JP)
- Tottori University (JP)
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/falgy.2025.1635540
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00